Related references
Note: Only part of the references are listed.Cardiovascular outcomes and conventional risk factors in non-diabetic adult patients with GH deficiency: A long-term retrospective cohort study
Cesare de Gregorio et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Management and interpretation of heterogeneous observational data: Using insulin-like growth factor-I data from the NordiNet® International Outcome Study
Oliver Blankenstein et al.
GROWTH HORMONE & IGF RESEARCH (2015)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2013)
Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study
Akira Shimatsu et al.
ENDOCRINE JOURNAL (2013)
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
Roger Abs et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Fifteen years of GH replacement improves body composition and cardiovascular risk factors
Mariam Elbornsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients
Mark L. Hartman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
Charlotte Höybye et al.
Clinical Epidemiology (2013)
Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone-Deficient Subjects During Growth Hormone Replacement Therapy A long-term observational study
Anton Luger et al.
DIABETES CARE (2012)
Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Guido Di Dalmazi et al.
JOURNAL OF NUTRITION AND METABOLISM (2012)
Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
Johan Verhelst et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
Mark E. Molitch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: A Surveillance Database Analysis
Andrea F. Attanasio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Niels Moller et al.
ENDOCRINE REVIEWS (2009)
Metabolic syndrome and incident diabetes - Current state of the evidence
Earl S. Ford et al.
DIABETES CARE (2008)
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia
Ken K. Y. Ho
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Unmasking other pituitary deficits during growth hormone replacement therapy
C. Giavoli
ANNALES D ENDOCRINOLOGIE (2007)
Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency
KCJ Yuen et al.
CLINICAL ENDOCRINOLOGY (2006)
Approved IFCC recommendation on reporting results for blood glucose
Paul D'Orazio et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Insulin sensitivity is impaired in adults with varying degrees of GH deficiency
RD Murray et al.
CLINICAL ENDOCRINOLOGY (2005)
Population-based incidence rates and risk factors for a type 2 diabetes in white individuals - The Bruneck study
E Bonora et al.
DIABETES (2004)
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging
JB Meigs et al.
DIABETES (2003)
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study
G Brabant et al.
HORMONE RESEARCH (2003)
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study
D Florakis et al.
CLINICAL ENDOCRINOLOGY (2000)
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency - A randomized, controlled clinical trial
G Sesmilo et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
